These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29575675)

  • 1. Novel oral anticoagulant use in adult Fontan patients: A single center experience.
    Georgekutty J; Kazerouninia A; Wang Y; Ermis PR; Parekh DR; Franklin WJ; Lam WW
    Congenit Heart Dis; 2018 Jul; 13(4):541-547. PubMed ID: 29575675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboprophylaxis in Adults With Atrio-Pulmonary Fontan.
    Small AJ; Aboulhosn JA; Lluri G
    World J Pediatr Congenit Heart Surg; 2018 Sep; 9(5):504-508. PubMed ID: 30157726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Direct Oral Anticoagulants in Adult Congenital Heart Disease.
    Pujol C; Niesert AC; Engelhardt A; Schoen P; Kusmenkov E; Pittrow D; Ewert P; Kaemmerer H
    Am J Cardiol; 2016 Feb; 117(3):450-5. PubMed ID: 26725103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease.
    Cheung YF; Leung MP
    J Paediatr Child Health; 1998 Dec; 34(6):563-7. PubMed ID: 9928651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
    Femia G; Fetahovic T; Shetty P; Lee A
    Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
    Yang H; Bouma BJ; Mulder BJM;
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):413-417. PubMed ID: 28785894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of thrombosis and anticoagulation post Fontan surgery.
    Attard C; Huang J; Monagle P; Ignjatovic V
    Thromb Res; 2018 Dec; 172():204-213. PubMed ID: 29685556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.
    Coleman CM; Khalaf S; Mould S; Wazni O; Kanj M; Saliba W; Cantillon D
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):731-7. PubMed ID: 25721150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulants in adults with congenital heart disease - a single centre study.
    Pujol C; Müssigmann M; Schiele S; Nagdyman N; Niesert AC; Kaemmerer H; Ewert P; Tutarel O
    Int J Cardiol; 2020 Feb; 300():127-131. PubMed ID: 31668654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
    Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY
    Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy.
    Egbe AC; Connolly HM; McLeod CJ; Ammash NM; Niaz T; Yogeswaran V; Poterucha JT; Qureshi MY; Driscoll DJ
    J Am Coll Cardiol; 2016 Sep; 68(12):1312-9. PubMed ID: 27634123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.
    Cheung YF; Chay GW; Chiu CS; Cheng LC
    Int J Cardiol; 2005 Jul; 102(3):509-13. PubMed ID: 16004898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era.
    Toth PP
    Vasc Health Risk Manag; 2016; 12():23-34. PubMed ID: 26929637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study.
    Lefebvre MC; St-Onge M; Glazer-Cavanagh M; Bell L; Kha Nguyen JN; Viet-Quoc Nguyen P; Tannenbaum C
    Can J Cardiol; 2016 Feb; 32(2):169-76. PubMed ID: 26277091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.
    Nascimento T; Birnie DH; Healey JS; Verma A; Joza J; Bernier ML; Essebag V
    Can J Cardiol; 2014 Feb; 30(2):231-6. PubMed ID: 24461924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.